Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.11
Price to sales ratio
21.58

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2962
AGMB
AgomAb Therapeutics NV - ADRs representing one
13.84 USD-3.08%+2.52%+10.37%-5.85%472.87 M USD
2968
DNA
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
7.27 USD+0.41%+1.96%-5.58%-18.13%467.75 M USD
2973
OCGN
Ocugen, Inc. - Common Stock
1.37 USD-2.84%-2.14%+9.60%+31.73%464.58 M USD
2980
ARCT
Arcturus Therapeutics Holdings Inc. - Common Stock
16.17 USD+2.15%+45.28%+181.22%-5.05%459.60 M USD

Frequently asked questions about Prothena Corporation plc Ordinary Shares

What is the Prothena Corporation plc Ordinary Shares stock price today?

The current price of Prothena Corporation plc Ordinary Shares (PRTA) is 9.09. Over the past 24 hours, the stock has changed by -1.73%. Follow the PRTA chart for real-time price dynamics.

What is the stock ticker of Prothena Corporation plc Ordinary Shares?

Prothena Corporation plc Ordinary Shares trades under the ticker PRTA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Prothena Corporation plc Ordinary Shares stock going up?

PRTA has changed by -0.22% over the last week, +5.21% over the last month, and +9.92% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Prothena Corporation plc Ordinary Shares?

Prothena Corporation plc Ordinary Shares currently has a market capitalization of 466.65 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Prothena Corporation plc Ordinary Shares earnings last quarter?

Last quarter, Prothena Corporation plc Ordinary Shares reported earnings of -0.36 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Prothena Corporation plc Ordinary Shares revenue for the last quarter?

Prothena Corporation plc Ordinary Shares reported quarterly revenue of 3.56 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Prothena Corporation plc Ordinary Shares net income for the last quarter?

Prothena Corporation plc Ordinary Shares reported net income of -18.58 M for the last quarter. The previous quarter showed 32.72 M, which means net income changed by -156.79%.

How many employees does Prothena Corporation plc Ordinary Shares have?

As of the latest available data, Prothena Corporation plc Ordinary Shares has 67 employees. Workforce size can provide additional context about the company's scale and operations.

What is Prothena Corporation plc Ordinary Shares EBITDA?

Prothena Corporation plc Ordinary Shares EBITDA is -18.35 M, and its EBITDA margin is -515.04%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Prothena Corporation plc Ordinary Shares stock?

You can buy Prothena Corporation plc Ordinary Shares (PRTA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Prothena Corporation plc Ordinary Shares stock?

Investing in Prothena Corporation plc Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PRTA chart and related analysis on metatrader.com as part of your research.

News